approval · primary record
DOXORUBICIN HYDROCHLORIDE
FDA · NDA · 2026-03-10
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-03-10 |
| Brand | DOXIL (LIPOSOMAL) |
| Sponsor | BAXTER HLTHCARE CORP |
| Route | INJECTION |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:49.336Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DOXORUBICIN HYDROCHLORIDE:2026-03-10
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.